Identification of Novel Core Genes Involved in Malignant Transformation of Inflamed Colon Tissue Using a Computational Biology Approach and Verification in Murine Models

Inflammatory bowel disease (IBD) is a complex and multifactorial systemic disorder of the gastrointestinal tract and is strongly associated with the development of colorectal cancer. Despite extensive studies of IBD pathogenesis, the molecular mechanism of colitis-driven tumorigenesis is not yet fully understood. In the current animal-based study, we report a comprehensive bioinformatics analysis of multiple transcriptomics datasets from the colon tissue of mice with acute colitis and colitis-associated cancer (CAC). We performed intersection of differentially expressed genes (DEGs), their functional annotation, reconstruction, and topology analysis of gene association networks, which, when combined with the text mining approach, revealed that a set of key overexpressed genes involved in the regulation of colitis (C3, Tyrobp, Mmp3, Mmp9, Timp1) and CAC (Timp1, Adam8, Mmp7, Mmp13) occupied hub positions within explored colitis- and CAC-related regulomes. Further validation of obtained data in murine models of dextran sulfate sodium (DSS)-induced colitis and azoxymethane/DSS-stimulated CAC fully confirmed the association of revealed hub genes with inflammatory and malignant lesions of colon tissue and demonstrated that genes encoding matrix metalloproteinases (acute colitis: Mmp3, Mmp9; CAC: Mmp7, Mmp13) can be used as a novel prognostic signature for colorectal neoplasia in IBD. Finally, using publicly available transcriptomics data, translational bridge interconnecting of listed colitis/CAC-associated core genes with the pathogenesis of ulcerative colitis, Crohn’s disease, and colorectal cancer in humans was identified. Taken together, a set of key genes playing a core function in colon inflammation and CAC was revealed, which can serve both as promising molecular markers and therapeutic targets to control IBD and IBD-associated colorectal neoplasia.

[1]  Yang Luo,et al.  Identification of CXCL10 and CXCL11 as the candidate genes involving the development of colitis-associated colorectal cancer , 2022, Frontiers in Genetics.

[2]  S. Asha Nair,et al.  Unfolding the cascade of SERPINA3: Inflammation to cancer. , 2022, Biochimica et biophysica acta. Reviews on cancer.

[3]  H. Yen,et al.  Chemoprevention of Colitis-Associated Dysplasia or Cancer in Inflammatory Bowel Disease , 2022, Gut and liver.

[4]  Weitao Hu,et al.  Identification of Differentially Expressed Genes and miRNAs for Ulcerative Colitis Using Bioinformatics Analysis , 2022, Frontiers in Genetics.

[5]  S. Iyer,et al.  Inflammatory bowel disease biomarkers , 2022, Medicinal research reviews.

[6]  B. Mroczko,et al.  A Disintegrin and Metalloproteinase (ADAM) Family—Novel Biomarkers of Selected Gastrointestinal (GI) Malignancies? , 2022, Cancers.

[7]  A. M’Koma,et al.  Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview , 2022 .

[8]  Jing Li,et al.  Incidence and Risk Factors for Cerebrovascular-Specific Mortality in Patients with Colorectal Cancer: A Registry-Based Cohort Study Involving 563,298 Patients , 2022, Cancers.

[9]  Ying Kong,et al.  Identification of Immune-Related Gene Signature and Prediction of CeRNA Network in Active Ulcerative Colitis , 2022, Frontiers in Immunology.

[10]  A. Sigamani,et al.  Inflammatory bowel disease-related colorectal cancer: Past, present and future perspectives , 2022, World journal of gastrointestinal oncology.

[11]  M. Camilleri.  Bile Acid Detergency: Permeability, Inflammation and Effects of Sulfation. , 2022, American journal of physiology. Gastrointestinal and liver physiology.

[12]  N. Suttorp,et al.  ADAM8 signaling drives neutrophil migration and ARDS severity , 2022, JCI insight.

[13]  Su Jin Lee,et al.  Promotion of the inflammatory response in mid colon of complement component 3 knockout mice , 2022, Scientific Reports.

[14]  S. Moss,et al.  LRG1: an emerging player in disease pathogenesis , 2022, Journal of biomedical science.

[15]  A. Bode,et al.  Prostaglandin Pathways: Opportunities for Cancer Prevention and Therapy , 2021, Cancer research.

[16]  Wei Zhang,et al.  ADAM8 Activates NLRP3 Inflammasome to Promote Cerebral Ischemia-Reperfusion Injury , 2021, Journal of healthcare engineering.

[17]  Yang Li,et al.  Identification of potential core genes in colorectal carcinoma and key genes in colorectal cancer liver metastasis using bioinformatics analysis , 2021, Scientific Reports.

[18]  G. D'Haens,et al.  The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms , 2021, International journal of molecular sciences.

[19]  S. Itzkowitz,et al.  Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management. , 2021, Gastroenterology.

[20]  J. Gisbert,et al.  Relationship between IGF-1 and body weight in inflammatory bowel diseases: Cellular and molecular mechanisms involved. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[21]  S. Danese,et al.  The Multiple Faces of Integrin–ECM Interactions in Inflammatory Bowel Disease , 2021, International journal of molecular sciences.

[22]  J. MacDonald,et al.  Molecular network analyses implicate death-associated protein kinase 3 (DAPK3) as a key factor in colitis-associated dysplasia progression , 2021, medRxiv.

[23]  A. Krüger,et al.  TIMP1 expression underlies sex disparity in liver metastasis and survival in pancreatic cancer , 2021, The Journal of experimental medicine.

[24]  S. Ramamoorthy,et al.  The Role of Biomarkers in Surgery for Ulcerative Colitis: A Review , 2021, Journal of clinical medicine.

[25]  G. Park,et al.  TrkB/C-induced HOXC6 activation enhances the ADAM8-mediated metastasis of chemoresistant colon cancer cells. , 2021, Molecular medicine reports.

[26]  Pengwang,et al.  Identification of hub genes and pathways in colitis-associated colon cancer by integrated bioinformatic analysis , 2021, BMC Genomic Data.

[27]  Jian Zhang,et al.  Tissue metabolic profiling reveals major metabolic alteration in colorectal cancer. , 2021, Molecular omics.

[28]  G. Monteleone,et al.  Metalloproteinases in Inflammatory Bowel Diseases , 2021, Journal of inflammation research.

[29]  S. Visweswariah,et al.  Impaired Intestinal Sodium Transport in Inflammatory Bowel Disease: From the Passenger to the Driver's Seat , 2021, Cellular and molecular gastroenterology and hepatology.

[30]  Hai-Yang Liao,et al.  Roles of matrix metalloproteinase-7 (MMP-7) in cancer. , 2021, Clinical biochemistry.

[31]  H. Itoh,et al.  Serum complement C3 and α2-macroglobulin are potentially useful biomarkers for inflammatory bowel disease patients , 2021, Heliyon.

[32]  M. Qiao,et al.  Identification of Crucial Genes and Related Transcription Factors in Ulcerative Colitis. , 2021, Annals of clinical and laboratory science.

[33]  P. Olczyk,et al.  The Role of Extracellular Matrix Components in Inflammatory Bowel Diseases , 2021, Journal of clinical medicine.

[34]  J. Samsom,et al.  Secretory Leukocyte Protease Inhibitor (SLPI) in mucosal tissues: Protects against inflammation, but promotes cancer. , 2021, Cytokine & growth factor reviews.

[35]  E. Nuti,et al.  Strategies to Target ADAM17 in Disease: From Its Discovery to the iRhom Revolution , 2021, Molecules.

[36]  Yinghao Cao,et al.  An Oxidative Stress Index-Based Score for Prognostic Prediction in Colorectal Cancer Patients Undergoing Surgery , 2021, Oxidative medicine and cellular longevity.

[37]  Nadezhda T. Doncheva,et al.  The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets , 2020, Nucleic Acids Res..

[38]  Junxiang Li,et al.  Identification of differentially expressed genes in ulcerative colitis and verification in a colitis mouse model by bioinformatics analyses , 2020, World journal of gastroenterology.

[39]  Meng-Xi Xiu,et al.  Identifying Hub Genes, Key Pathways and Immune Cell Infiltration Characteristics in Pediatric and Adult Ulcerative Colitis by Integrated Bioinformatic Analysis , 2020, Digestive Diseases and Sciences.

[40]  A. Kwong,et al.  Human haptoglobin contributes to breast cancer oncogenesis through glycolytic activity modulation. , 2020, American journal of cancer research.

[41]  P. Vivas-Mejia,et al.  Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer , 2020, International journal of molecular sciences.

[42]  Eun Jung Lee,et al.  Meta-Analysis of Expression Profiling Data Indicates Need for Combinatorial Biomarkers in Pediatric Ulcerative Colitis , 2020, Journal of immunology research.

[43]  Zhong-Xi Huang,et al.  GenCLiP 3: mining human genes' functions and regulatory networks from PubMed based on co-occurrences and natural language processing , 2019, Bioinform..

[44]  R. Nakov.  New markers in ulcerative colitis. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[45]  A. Kel,et al.  Deep insights into the response of human cervical carcinoma cells to a new cyano enone-bearing triterpenoid soloxolone methyl: a transcriptome analysis , 2019, Oncotarget.

[46]  Xudong Tang,et al.  Investigation of Potential Genetic Biomarkers and Molecular Mechanism of Ulcerative Colitis Utilizing Bioinformatics Analysis , 2019, BioMed research international.

[47]  Minglei Yang,et al.  Analysis of Genes Involved in Ulcerative Colitis Activity and Tumorigenesis Through Systematic Mining of Gene Co-expression Networks , 2019, Front. Physiol..

[48]  J. Hua,et al.  Identification of differentially expressed genes, associated functional terms pathways, and candidate diagnostic biomarkers in inflammatory bowel diseases by bioinformatics analysis , 2019, Experimental and therapeutic medicine.

[49]  C. Nimsky,et al.  ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance. , 2019, Clinical science.

[50]  Jan Gorodkin,et al.  Cytoscape stringApp: Network analysis and visualization of proteomics data , 2018, bioRxiv.

[51]  John H. Morris,et al.  Cytoscape stringApp: Network analysis and visualization of proteomics data , 2018, bioRxiv.

[52]  H. Hammad,et al.  The emerging role of ADAM metalloproteinases in immunity , 2018, Nature Reviews Immunology.

[53]  R. Eri,et al.  NLRP3 inflammasome in colitis and colitis-associated colorectal cancer , 2018, Mammalian Genome.

[54]  M. Mahdavi,et al.  Calprotectin (S100A8/S100A9): a key protein between inflammation and cancer , 2018, Inflammation Research.

[55]  C. Sina,et al.  The intestinal complement system in inflammatory bowel disease: Shaping intestinal barrier function. , 2018, Seminars in immunology.

[56]  M. Huber-Lang,et al.  Regulation of epithelial cell expressed C3 in the intestine - Relevance for the pathophysiology of inflammatory bowel disease? , 2017, Molecular immunology.

[57]  Poonam K Sharma,et al.  Significant association of TREM-1 with HMGB1, TLRs and RAGE in the pathogenesis of insulin resistance in obese diabetic populations. , 2017, American journal of translational research.

[58]  A. Kong,et al.  Mechanisms of colitis‐accelerated colon carcinogenesis and its prevention with the combination of aspirin and curcumin: Transcriptomic analysis using RNA‐seq , 2017, Biochemical pharmacology.

[59]  S. Vermeire,et al.  Inhibition of gelatinase B/MMP-9 does not attenuate colitis in murine models of inflammatory bowel disease , 2017, Nature Communications.

[60]  F. Liang,et al.  Enhanced construction of gene regulatory networks using hub gene information , 2017, BMC Bioinformatics.

[61]  S. Vermeire,et al.  Genetic Deletion of Tissue Inhibitor of Metalloproteinase-1/TIMP-1 Alters Inflammation and Attenuates Fibrosis in Dextran Sodium Sulphate-induced Murine Models of Colitis. , 2016, Journal of Crohn's & colitis.

[62]  E. Roeb,et al.  Matrix metalloproteinase-13 refines pathological staging of precancerous colorectal lesions , 2016, Oncotarget.

[63]  Jordan Anaya,et al.  OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs , 2016, PeerJ Comput. Sci..

[64]  Aiping Lu,et al.  Triptolide Modulates TREM-1 Signal Pathway to Inhibit the Inflammatory Response in Rheumatoid Arthritis , 2016, International journal of molecular sciences.

[65]  M. Fung,et al.  Strategies targeting the IL-4/IL-13 axes in disease. , 2015, Cytokine.

[66]  R. Minghim,et al.  InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams , 2015, BMC Bioinformatics.

[67]  J. Gilmer,et al.  Matrix Metalloproteinases in Inflammatory Bowel Disease: An Update , 2015, Mediators of inflammation.

[68]  Lei Wang,et al.  Expression of A disintegrin and metalloprotease 8 is associated with cell growth and poor survival in colorectal cancer , 2014, BMC Cancer.

[69]  Y. Urade,et al.  Mast cell-derived prostaglandin D2 inhibits colitis and colitis-associated colon cancer in mice. , 2014, Cancer research.

[70]  S. Rutella,et al.  The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation , 2014, Gut.

[71]  G. Rogler,et al.  Chronic ulcerative colitis and colorectal cancer. , 2014, Cancer letters.

[72]  Y. Wang,et al.  Neutrophil infiltration favors colitis-associated tumorigenesis by activating the interleukin-1 (IL-1)/IL-6 axis , 2014, Mucosal Immunology.

[73]  M. Colonna,et al.  Role of TREM1-DAP12 in Renal Inflammation during Obstructive Nephropathy , 2013, PloS one.

[74]  S. Grivennikov.  Inflammation and colorectal cancer: colitis-associated neoplasia , 2013, Seminars in Immunopathology.

[75]  S. Landas,et al.  Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease , 2012, Inflammatory bowel diseases.

[76]  Sean R. Davis,et al.  NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..

[77]  Yudong D. He,et al.  Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers , 2012, Molecular systems biology.

[78]  Wei-Li Di,et al.  Inflammatory skin and bowel disease linked to ADAM17 deletion. , 2011, The New England journal of medicine.

[79]  Steven J. M. Jones,et al.  Circos: an information aesthetic for comparative genomics. , 2009, Genome research.

[80]  Jing Chen,et al.  ToppGene Suite for gene list enrichment analysis and candidate gene prioritization , 2009, Nucleic Acids Res..

[81]  T. Kirkegaard,et al.  Spontaneous and cytokine induced expression and activity of matrix metalloproteinases in human colonic epithelium , 2009, Clinical and experimental immunology.

[82]  Hua-mei Tang,et al.  Gene‐expression profiling in Chinese patients with colon cancer by coupling experimental and bioinformatic genomewide gene‐expression analyses , 2008, Cancer.

[83]  Fidel Ramírez,et al.  Computing topological parameters of biological networks , 2008, Bioinform..

[84]  Takuji Tanaka,et al.  Global gene expression analysis of the mouse colonic mucosa treated with azoxymethane and dextran sodium sulfate , 2007, BMC Cancer.

[85]  K. Imai,et al.  Therapeutic implications of the specific inhibition of causative matrix metalloproteinases in experimental colitis induced by dextran sulphate sodium , 2006, The Journal of pathology.

[86]  Takuji Tanaka,et al.  A novel inflammation‐related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate , 2003, Cancer science.

[87]  F. Baldelli,et al.  Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases. , 2017, Inflammatory bowel diseases.

[88]  P. Garg,et al.  Role of Matrix Metalloproteinases in Inflammation/Colitis-Associated Colon Cancer , 2013 .